ResearcherZhejiang Provincial People's HospitalNo recent work listed
Peng-Fei Zhu
Matched on ORCID iD 0000-0001-7328-4161; OpenAlex author ID A5021464011. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2021: 1 paper · 2022: 1 paper · 2023: 1 paper
Papers 3
- Third-line treatment options in metastatic pancreatic cancer patients: a real-world study. First author DOI 10.3389/fonc.2023.1251258↗
- Tumor-mutation burden as a marker for immunotherapy of pancreatic cancer: the case report and literature review. Co-author DOI 10.1097/cad.0000000000001232↗
- Conversion Therapy of Unresectable Pancreatic Cancer: A Retrospective Study of the Real World First author DOI 10.21203/rs.3.rs-674137/v1↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zheling Chen · 3 shared papers, 2021–2023 · strength 0.60
- Paper Third-line treatment options in metastatic pancreatic cancer patients: a real-world study. DOI 10.3389/fonc.2023.1251258↗
- Paper Conversion Therapy of Unresectable Pancreatic Cancer: A Retrospective Study of the Real World DOI 10.21203/rs.3.rs-674137/v1↗
- Paper Tumor-mutation burden as a marker for immunotherapy of pancreatic cancer: the case report and literature review. DOI 10.1097/cad.0000000000001232↗
- Liu Yang · 2 shared papers, 2021–2023 · strength 0.43
- Mingxing Wang · 2 shared papers, 2021–2022 · strength 0.37
- Hongrui Lu · 1 shared paper, 2023 · strength 0.24
- Yang Liu · 1 shared paper, 2022 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.